Articles with the keyword: 


When the past catches up with the present
sea-maid submitted, created time 3 weeks 10 hours (www.nature.com)
Oversight committees face tough decisions after an analysis questions whether certain cell lines meet standards of informed consent. If not, then the number of stem cell lines that U.S. scientists may study with federal funding may drop from twenty-one to sixteen. 


Induced stem cell lines may soon be available from Harvard
Darkfrog submitted, created time 4 weeks 2 days (sciencenow.sciencemag.org)
A few weeks ago, we talked about how researchers had been able to take a cell from an ALS patient and develop a working, research-quality pluripotent cell line. Well the next step has been taken.
I've been saying that induced pluripotent stem cells might become the preferred research model (over embryonic stem cells), but only if they became easier to obtain than embryonic stem cells. It looks as though that might happen soon. The Harvard Stem Cell Institute is dedicating an iPS core lab 
Consent issues restrict stem-cell use and research
sea-maid submitted, created time 1 month 1 week (www.nature.com)
Some researchers in Stanford University are told that around one-quarter of the human embryonic stem-cell lines eligible for U.S. government funding are now off-limits because of ethical concerns. The university is concerned that some of the women who donated the embyros that were used to generate the line might not have been fully informed of how they would be used.
The consent forms that the women signed were retrieved and it was found that none of them met Standford's guidelines exactly and some of them were way off the mark 
Drugmakers Fund Journalism Group
kavin submitted, created time 1 month 1 week (blogs.wsj.com)
Doctors and medical associations have taken plenty of lumps for relying on drug companies to sponsor continuing medical education courses. Critics say the sessions are often biased in favor of a particular medicine or drugs over alternative treatments for disease.
Now add journalists to the groups that are getting professional education subsidized by Big Pharma.
At the Unity convention in Chicago-–a gathering of thousands of minority journalists-–the diabetes drug maker Novo Nordisk sponsored a lunch yesterday called, “The Diabetes Explosion: A Call to Action for Journalists of Color 


Stem cell meeting 2008: complications for induced pluripotent stem cells
sea-maid submitted, created time 1 month 2 weeks (www.nature.com)
This year's meeting of the International Society for Stem Cell Research in Philadelphia, Pennsylvania, included a jam-packed session on the standards and methodologies of creating induced pluripotent stem cells. But although excitement around advances in reprogramming somatic cells shows no signs of abating, new ideas regarding the field are surfacing.
One announcement in particular may have consequences for induced pluripotent stem cells: It seems that ever reprogrammed cells can retain some echoes of their differentiated states, which researchers have nicknamed "cellular memory 


Nature takes a look at in-vitro fertilization's past, present and future
Darkfrog submitted, created time 1 month 2 weeks (www.nature.com)
This article is a comprehensive look at the past and future of artificial babymaking. It covers IVF, the possible use of iPS to make gametes. It covers ethics, public relations, and economics...
The part that I like best? IVF has "gone as far as it can" with regards to what it can do, so the next focus is on making it cheaper. The article discusses the woman in a developing country who, on top of her own wishes for a family, faces discrimination for her infertility 


U.S. doctors display "No drug reps" signs
jerry submitted, created time 1 month 3 weeks (www.bmj.com)
U.S. doctors who refuse to see drug companies’ sales representatives can now display a sign, similar to a "No smoking" sign, in their offices.
The certificate says that the doctor’s office "does not allow visits from pharmaceutical salespeople because we rely on scientific information, not marketing, to decide what treatment is best for you." It adds: "This policy also means that we don’t provide drug samples."
"‘Free’ drug samples cost you money," it says, because they are promoted only for the most expensive drugs.
The idea of the signs is being promoted by PharmedOut 


Harvesting stem cells at the four-cell stage can be easier and safer
Darkfrog submitted, created time 1 month 4 weeks (blog.wired.com)
Here is a Wired Science writeup of that article I posted yesterday. It's less detailed, but it's easier to read. Again, the top story is that researchers have found a new way to harvest stem cells from embryos without destroying them: taking a cell at the four-cell stage produces cell lines that don't need to be co-cultured. And we already know from fertility treatments that the remaining three cells can grow into healthy children. 


They're calling it "biological alchemy": induced stem cells proliferate
sea-maid submitted, created time 1 month 4 weeks (www.newscientist.com)
CALL it biological alchemy: specialist pancreatic cells that secrete digestive enzymes have been converted directly into insulin-producing beta cells. Meanwhile, epithelial cells from the back of the eye have been coaxed into becoming a versatile, new type of stem cell.
Both advances, reported last week in Philadelphia, Pennsylvania, at the annual meeting of the International Society for Stem Cell Research (ISSCR), may take us closer to a "regenerative" approach to repairing damaged tissue 


sea-maid submitted, created time 2 months 1 week (sciencenow.sciencemag.org)
The main strength of the paper is that it shows how the two different "moral motivations" were isolated and details the investigation of how they are represented in the brain. 


Does medical research need a sunshine law?
Darkfrog submitted, created time 2 months 2 weeks (www.nature.com)
A U.S. supreme court justice once said, "Sunshine is the best disinfectant." The sunshine here, is a metaphor for disclosure. The idea is that once the information is out in the open, corruption will disappear 


Stem cell researchers face down stem cell tourism
sea-maid submitted, created time 2 months 4 weeks (www.nature.com)
"Stem cell tourism," in which people travel thousands of miles and pay thousands of dollars to receive unregulated care, is nothing new. Now, with more stem cell applications being pushed toward clinical trials, the international research community is stepping up.
Although some of the patients report positive results, the fact that they cannot describe their treatments in detail--or produce verifiable medical records--severely limits the research value (though not the human value) of their cases 


Google launches free patient records
sea-maid submitted, created time 3 months 4 days (www.bmj.com)
The search engine giant has launched Google Health, a free service for patients offering a personal electronic medical record, but the move has prompted fears over the security of health information stored in this way. 


Stopping clinical trials early
sea-maid submitted, created time 3 months 6 days (www.bmj.com)
Should we be worried about an apparent rise in the number of clinical trials now being stopped early because the results are so good? Margaret McCartney asks how convincing should results be before trials are halted - and what the implications are for patients. 


Genetic Information Nondescrimination Act passes!!
Darkfrog submitted, created time 4 months 1 week (www.nature.com)
The Genetic Information Nondescrimination Act has passed in the U.S. government. Now employers and insurance companies are forbidden on the federal level to use the results of genetic testing to hire, fire or give or deny insurance. Basically, this means that the movie Gataca won't happen in real life. 